12+ hour, 4+ min ago   (330+ words) Huinno, a digital healthcare company specializing in AI-powered cardiac monitoring, has passed the technology assessment required for a technology-based special listing on Kosdaq, moving a step closer to an initial public offering. Intermittent arrhythmias can be difficult to detect through…...

4+ day, 5+ hour ago   (226+ words) Korea Biomedical Review Samsung Biologics said Thursday it had signed a 350.8 billion won ($261 million) contract to manufacture a biologic drug for an unnamed European pharmaceutical company, running through 2033. The Korean contract drug manufacturer disclosed the deal in a regulatory filing,…...

4+ day, 5+ hour ago   (274+ words) Dong-A Socio Holdings, the holding company behind one of Korea's oldest drugmakers, plans to rename itself Dong-A Pharmaceutical and directly operate its consumer healthcare business after absorbing its over-the-counter (OTC) subsidiary. Shareholders will vote Sept. 22 on a charter change that…...

4+ day, 7+ hour ago   (192+ words) Korean cosmetics contract manufacturer COSMECCA KOREA said on Thursday it will invest 200 billion won ($150 million) to build a new skincare production complex, betting on sustained global demand for Korean beauty (K-beauty) products. The company, which makes cosmetics on an original…...

4+ day, 7+ hour ago   (440+ words) Celltrion is stepping up efforts to expand sales of its omalizumab biosimilar Omlyclo across Europe, building on an estimated market share exceeding 90 percent in Spain and sales above its business target in Italy, the company said Thursday. Omlyclo, used to…...

4+ day, 9+ hour ago   (459+ words) Korea’s rare-disease drug market grew nearly fivefold over the past decade to about 1.2 trillion won ($896 million) in 2025, outpacing the broader pharmaceutical market, according to an IQVIA Korea analysis. IQVIA Korea said Thursday the findings were based on sales data from…...

4+ day, 12+ hour ago   (198+ words) Korea Biomedical Review Yuyu Pharma CEO Robert Yu has launched “Robert’s YUniverse,” a podcast featuring conversations with guests on topics ranging from animal health research to Korean culture and global business. Yu, a third-generation member of the company’s founding family, hosts…...

5+ day, 8+ hour ago   (386+ words) The head of the United Arab Emirates' pharmaceutical regulator visited Biosolution and Helixmith's research center in Seoul to discuss regulatory cooperation and potential market entry for Korean cell and gene therapies in the Middle East. Biosolution said Wednesday that Fatima…...

6+ day, 6+ hour ago   (1179+ words) The government will gradually cut health insurance copayments for patients with rare and severe intractable diseases from 10 percent to 7 percent this year and 5 percent in 2028. The government will also expand support for insulin pumps and continuous glucose monitors to patients…...

6+ day, 6+ hour ago   (348+ words) The government has decided to freeze the national health insurance premium rate at 7.19 percent in 2027, citing stable finances and expected support from the government and premium revenue. The Ministry of Health and Welfare said that the Health Insurance Policy Deliberation…...